Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Anticancer Research
|
October 28, 2025
Very Rapid Eradication of a Large Squamous-Cell Carcinoma of the Head and Neck Treated With First-line Combination Chemotherapy, a Low-methionine Diet, and Oral Recombinant Methioninase
Yohei Asano, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
November 29, 2025
Selective Synergy of the Combination of Recombinant Methioninase With Cisplatinum and Ivermectin Which Eradicates Lung-Cancer Cells but Has No Synergy and Limited Effect on Normal Fibroblasts
Yohei Asano, Qinghong Han, Shukuan Li, et al.
Cancer Research
|
September 18, 2004
PEGylation confers greatly extended half-life and attenuated immunogenicity to recombinant methioninase in primates
Zhijian Yang, Junhua Wang, Quan Lu, et al.
Anticancer Research
|
November 29, 2025
FDG- and MET-PET Imaging Reveal Glucose and Methionine Addiction in a Primary Endometrial Cancer and Methionine Addiction only in a Para-aortic Lymph-node Metastasis in a 58-year-old Patient
Yohei Asano, Toshihiko Sato, Chihiro Hozumi, et al.
Anticancer Research
|
November 29, 2025
Rapid Eradication of Extensive Spinal Metastases in a Prostate-Cancer Patient Taking Androgen-deprivation Therapy, Chemotherapy, and Oral Recombinant Methioninase on a Low-Methionine Diet
Yohei Asano, Qinghong Han, Shukuan Li, et al.
Oncotarget
|
February 9, 2018
Recombinant methioninase (rMETase) is an effective therapeutic for BRAF-V600E-negative as well as -positive melanoma in patient-derived orthotopic xenograft (PDOX) mouse models
Kei Kawaguchi, Kentaro Igarashi, Shukuan Li, et al.
Cancer Diagnosis & Prognosis
|
September 3, 2025
Eradication of Extensive Lymph-Node, Bone and Pleural Metastases of a Breast-Cancer Patient Treated With Radiation, Immunotherapy and Oral Recombinant Methioninase
Yohei Asano, Toshihiko Sato, Qinghong Han, et al.
Oncotarget
|
March 16, 2018
Intra-tumor L-methionine level highly correlates with tumor size in both pancreatic cancer and melanoma patient-derived orthotopic xenograft (PDOX) nude-mouse models
Kei Kawaguchi, Qinghong Han, Shukuan Li, et al.
Cell Cycle (Georgetown, Tex.)
|
December 1, 2017
Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for chronic clinical cancer therapy and prevention
Kei Kawaguchi, Qinghong Han, Shukuan Li, et al.
Journal of Cellular Biochemistry
|
November 17, 2017
Growth of doxorubicin-resistant undifferentiated spindle-cell sarcoma PDOX is arrested by metabolic targeting with recombinant methioninase
Kentaro Igarashi, Shukuan Li, Qinghong Han, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Anticancer Research
|
October 28, 2025
Very Rapid Eradication of a Large Squamous-Cell Carcinoma of the Head and Neck Treated With First-line Combination Chemotherapy, a Low-methionine Diet, and Oral Recombinant Methioninase
Yohei Asano, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
November 29, 2025
Selective Synergy of the Combination of Recombinant Methioninase With Cisplatinum and Ivermectin Which Eradicates Lung-Cancer Cells but Has No Synergy and Limited Effect on Normal Fibroblasts
Yohei Asano, Qinghong Han, Shukuan Li, et al.
Cancer Research
|
September 18, 2004
PEGylation confers greatly extended half-life and attenuated immunogenicity to recombinant methioninase in primates
Zhijian Yang, Junhua Wang, Quan Lu, et al.
Anticancer Research
|
November 29, 2025
FDG- and MET-PET Imaging Reveal Glucose and Methionine Addiction in a Primary Endometrial Cancer and Methionine Addiction only in a Para-aortic Lymph-node Metastasis in a 58-year-old Patient
Yohei Asano, Toshihiko Sato, Chihiro Hozumi, et al.
Anticancer Research
|
November 29, 2025
Rapid Eradication of Extensive Spinal Metastases in a Prostate-Cancer Patient Taking Androgen-deprivation Therapy, Chemotherapy, and Oral Recombinant Methioninase on a Low-Methionine Diet
Yohei Asano, Qinghong Han, Shukuan Li, et al.
Oncotarget
|
February 9, 2018
Recombinant methioninase (rMETase) is an effective therapeutic for BRAF-V600E-negative as well as -positive melanoma in patient-derived orthotopic xenograft (PDOX) mouse models
Kei Kawaguchi, Kentaro Igarashi, Shukuan Li, et al.
Cancer Diagnosis & Prognosis
|
September 3, 2025
Eradication of Extensive Lymph-Node, Bone and Pleural Metastases of a Breast-Cancer Patient Treated With Radiation, Immunotherapy and Oral Recombinant Methioninase
Yohei Asano, Toshihiko Sato, Qinghong Han, et al.
Oncotarget
|
March 16, 2018
Intra-tumor L-methionine level highly correlates with tumor size in both pancreatic cancer and melanoma patient-derived orthotopic xenograft (PDOX) nude-mouse models
Kei Kawaguchi, Qinghong Han, Shukuan Li, et al.
Cell Cycle (Georgetown, Tex.)
|
December 1, 2017
Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for chronic clinical cancer therapy and prevention
Kei Kawaguchi, Qinghong Han, Shukuan Li, et al.
Journal of Cellular Biochemistry
|
November 17, 2017
Growth of doxorubicin-resistant undifferentiated spindle-cell sarcoma PDOX is arrested by metabolic targeting with recombinant methioninase
Kentaro Igarashi, Shukuan Li, Qinghong Han, et al.
Page
of 6